Serdar TÜRKYILMAZ, Ali GÜNER, Mehmet ULUŞAHİN, Arif Burak ÇEKİÇ, Aydın AKTAŞ, Muhammet ATEŞ, Murat Emre REİS

Perioperative or intraoperative blood transfusion increases the risk of postoperative pancreatic fistula following pancreaticoduodenectomy

Aim: Postoperative pancreatic fistula (POPF) is one of the most common causes of morbidity following pancreaticoduodenectomy (PD). The optimum way of reducing the prevalence of POPF is to prevent its development. In this study, we attempted to identify the potential perioperative risk factors of POPF and suggestions were made for its. Material and Methods: In this study, we included patients who had undergone PD from January 2010 to April 2020. POPF was defined as per the International Study Group on Pancreatic Fistula. The patients were followed up for 30 days for POPF.Results: Fifty-two (52) patients whose medical records were available were enrolled. POPF developed in 19 patients (36.5%). Grade-A POPF developed in six patients (11.5%), Grade-B POPF in eight patients (15.4%), and Grade-C POPF in five patients (9.6%). Percutaneous drainage was performed in a patient with Grade-B POPF, and reoperation was performed for five patients with Grade-C POPF. In univariate analysis, female sex (p=0.03), perioperative blood transfusion (p=0.03), and the number of harvested lymph nodes ≥12 (p=0.008) were related to POPF. In logistic regression analysis, the number of harvested lymph nodes ≥12 (p=0.005) and female sex (p=0.03) were independent risk factors of POPF. Although perioperative blood transfusion increased the POPF risk, the effect was not statistically significant (p=0.10).Conclusion: POPF was observed to be the most important cause of morbidity following PD in our study. We also found that reduce the POPF risk, it is important to avoid blood transfusion whenever possible.

PDF

___

1. Qin H, Luo L, Zhu Z, et al. Pancreaticogastrostomy has advantages over pancreaticojejunostomy on pancreatic fistula after pancreaticoduodenectomy. A meta-analysis of randomized controlled trials. Int J Surg 2016;36:18-24.
2. Ramacciato G, Mercantini P, Petrucciani N, et al. Risk factors of pancreatic fistula after pancreaticoduodenectomy: a collective review. Am Surg 2011;77:257-69.
3. Chen JS, Liu G, Li TR, et al. Pancreatic fistula after pancreaticoduodenectomy: Risk factors and preventive strategies. J Cancer Res Ther 2019;15:857- 63.
4. Ke ZX, Xiong JX, Hu J, et al. Risk Factors and Management of Postoperative Pancreatic Fistula Following Pancreaticoduodenectomy: Single-center Experience. Curr Med Sci 2019;39:1009-18.
5. Bassi C, Falconi M, Molinari E, et al. Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: results of a comparative study. Ann Surg 2005;242:767-73.
6. Pan SB, Geng W, Zhou DC, et al. One-layer versus two-layer duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy: study protocol for a randomized controlled trial. Trials 2016;17:407.
7. Fujii T, Sugimoto H, Yamada S, et al. Modified Blumgart anastomosis for pancreaticojejunostomy: technical improvement in matched historical control study. J Gastrointest Surg 2014;18:1108-15.
8. Winter JM, Cameron JL, Campbell KA, et al. Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg 2006;10:1280-90.
9. Shan YS, Sy ED, Lin PW. Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in highrisk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial. World J Surg 2003;27:709-14.
10. Hu BY, Wan T, Zhang WZ, et al. Risk factors for postoperative pancreatic fistula: Analysis of 539 successive cases of pancreaticoduodenectomy. World J Gastroenterol 2016;22:7797-805.
11. Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery 2017;161:584-91.
12. Xiong JJ, Tan CL, Szatmary P, et al. Metaanalysis of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Br J Surg 2014;101:1196–208.
13. Allen PJ, Gönen M, Brennan MF, et al: Pasireotide for postoperative pancreatic fistula. N Engl J Med 2014;370:2014–22.
14. Sandini M, Malleo G, Gianotti L. Scores for prediction of fistula after Pancreatoduodenectomy: A Systematic Review. Dig Surg 2016;33:392-400.
15. Polanco PM, Zenati MS, Hogg ME, et al. An analysis of risk factors for pancreatic fistula after robotic pancreaticoduodenectomy: outcomes from a consecutive series of standardized pancreatic reconstructions. Surg Endosc 2016;30:1523-9.
16. Kim Y, Bagante F, Gani F, et al. Nomogram to predict perioperative blood transfusion for hepatopancreaticobiliary and colorectal surgery. Br J Surg 2016;103:1173–83.
17. Yuruk K, Bartels SA, Milstein DM, et al. Red blood cell transfusions and tissue oxygenation in anemic hematology outpatients. Transfusion 2012;52:641-6.
18. Bansal SS, Hodson J, Khalil K, et al. Distinct risk factors for early and late blood transfusion following pancreaticoduodenectomy. Hepatobiliary Pancreat Dis Int 2018;17:349-357.
19. Cheng Y, Briarava M, Lai M, et al. Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy. Cochrane Database Syst Rev 2017;9:CD012257.
20. Topal B, Fieuws S, Aerts R, et al. Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy for pancreatic or periampullary tumours: a multicentre randomized trial. Lancet Oncol 2013;14:655-62.
21. Menahem B, Guittet L, Mulliri A, et al. Pancreaticogastrostomy is superior to pancreaticojejunostomy for prevention of pancreatic fistula after pancreaticoduodenectomy: an updated meta-analysis of randomized controlled trials. Ann Surg 2015;261:882-87.
22. Que W, Fang H, Yan B, et al. Pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials. Am J Surg 2015;209:1074-82.
23. Sutton CD, Garcea G, White SA, et al. Isolated Rouxloop pancreaticojejunostomy: a series of 61 patients with zero postoperative pancreaticoenteric leaks. J Gastrointest Surg 2004;8:701–5.
24. Erdem H, Çetinkünar S, Aziret M, et al. Can isolated pancreaticojejunostomy reduce pancreas fistula after pancreaticoduodenectomy with Roux-en-Y reconstruction? Ulus Cerrahi Derg 2016;32:248-51.
25. Tani M, Kawai M, Hirono S, et al. Randomized clinical trial of isolated Roux-en-Y versus conventional reconstruction after pancreaticoduodenectomy. Br J Surg 2014;101:1084-91.
26. Klaiber U, Probst P, Knebel P, et al. Meta-analysis of complication rates for single-loop versus dual-loop (Roux-en-Y) with isolated pancreaticojejunostomy reconstruction after pancreaticoduodenectomy. Br J Surg 2015;102:331-40.
27. Kamoda Y, Fujino Y, Matsumoto I, et al. Usefulness of performing a pancreaticojejunostomy with an internal stent after a pancreatoduodenectomy. Surg Today 2008;38:524-48.
28. Dong Z, Xu J, Wang Z, et al. Stents for the prevention of pancreatic fistula following pancreaticoduodenectomy. Cochrane Database Syst Rev 2016;5:CD008914.
29. Zhao R, Chang Y, Wang X, et al. Pylorus-preserving pancreaticoduodenectomy versus standard pancreaticoduodenectomy in the treatment of duodenal papilla carcinoma. Oncol Lett 2018;15:6368- 76.
30. Lin PWi Lin YJ: Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg 1999:86:603-7.
31. Seiler CA, Wagner M, Bachmann T, et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg. 2005:92:547- 56.
32. Tran KT, Smeenk HG, van Eijck CH, et al. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: A prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 2004:240:738-45.
33. Schwarz RE, Smith DD. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol 2006;13:1189-2000.
34. Pedrazzoli S. Extent of lymphadenectomy to associate with pancreaticoduodenectomy in patients with pancreatic head cancer for better tumor staging. Cancer Treat Rev 2015;41:577-87.